Reliance Pharmaceuticals Private Limited - Stock Valuation and Financial Performance

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Reliance Pharmaceuticals Private Li

M-Cap below 100cr DeciZen not available

Reliance Pharmaceuticals Private Limite stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
0 Cr.
52-wk low:
0
52-wk high:
0

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray of Reliance Pharmaceuticals Private Li:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'09Mar'10TTM
ROCE % -2.8%-2.7%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 10.30
Sales YoY Gr.--74.5%-
Adj EPS -13,130.6-9,904.10
YoY Gr.-NA-
BVPS (₹) -13,120.6-23,024.70
Adj Net
Profit
-13.1-9.90
Cash Flow from Ops. -237-77.1-
Debt/CF from Ops. -2-3.9-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANANA-74.5%
Adj EPS NANANANA
BVPSNANANANA
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'09Mar'10TTM
Return on
Equity %
100.154.80
Op. Profit
Mgn %
-1288.1-3904.8NAN
Net Profit
Mgn %
-1346.2-4004.90
Debt to
Equity
-36.2-13-
Working Cap
Days
03,91,6070
Cash Conv.
Cycle
0-24,9380

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Reliance Pharmaceuticals Private Limited

Standalone Consolidated
TTM EPS (₹) 0 -
TTM Sales (₹ Cr.) 0.3 -
BVPS (₹.) 0 -
Reserves (₹ Cr.) -23 -
P/BV 0.00 -
PE 0.00 -
From the Market
52 Week Low / High (₹) - / -
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 0
Equity (₹ Cr.) 0
Face Value (₹) 10
Industry PE 48.8

Management X-Ray of Reliance Pharmaceuticals Private Li:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Reliance Pharmaceuticals Private Li

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'09Mar'10
Sales0.980.25
Operating Expenses 13.549.90
Manufacturing Costs00
Material Costs00
Employee Cost 00
Other Costs 13.549.90
Operating Profit -12.56-9.66
Operating Profit Margin (%) -1,288.1%-3,904.8%
Other Income 00
Interest 00
Depreciation 0.500.25
Exceptional Items 00
Profit Before Tax -13.06-9.90
Tax 0.070
Profit After Tax -13.13-9.90
PAT Margin (%) -1,346.2%-4,004.9%
Adjusted EPS (₹)-13,130.6-9,904.1
Dividend Payout Ratio (%)0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'09Mar'10

Equity and Liabilities

Shareholders Fund -13.12-23.02
Share Capital 0.010.01
Reserves -13.13-23.03
Minority Interest00
Debt475298.61
Long Term Debt475298.61
Short Term Debt00
Trade Payables20.9917.22
Others Liabilities 1.550
Total Liabilities 484.41292.80

Fixed Assets

Gross Block215.860
Accumulated Depreciation0.500
Net Fixed Assets215.360
CWIP 3.260
Investments 0.010.01
Inventories3.190
Trade Receivables1.200
Cash Equivalents 27.710.22
Others Assets233.70292.58
Total Assets 484.41292.80

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'09Mar'10
Cash Flow From Operating Activity -237.21-77.12
PBT -13.06-9.90
Adjustment 0.540.94
Changes in Working Capital -224.63-68.16
Tax Paid -0.060
Cash Flow From Investing Activity -192.59157.87
Capex -192.59157.53
Net Investments -0.010
Others 00.35
Cash Flow From Financing Activity 457.38-108.04
Net Proceeds from Shares 00
Net Proceeds from Borrowing 00
Interest Paid -0.03-0.95
Dividend Paid 00
Others 457.40-107.09
Net Cash Flow 27.57-27.29
PARTICULARSMar'09Mar'10
Ratios
ROE (%)N/AN/A
ROCE (%)N/AN/A
Asset Turnover Ratio00
PAT to CFO Conversion(x)N/AN/A
Working Capital Days
Receivable Days4480
Inventory Days1,1920
Payable Days00

Reliance Pharmaceuticals Private Limited Stock News

Reliance Pharmaceuticals Private Limited FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Reliance Pharmaceuticals Private Li on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Reliance Pharmaceuticals Private Li stood at ₹0.00.
The latest P/E ratio of Reliance Pharmaceuticals Private Li as of 01-Jan-1970 05:30 is 0.00.
The latest P/B ratio of Reliance Pharmaceuticals Private Li as of 01-Jan-1970 05:30 is 0.00.
The 52-week high of Reliance Pharmaceuticals Private Li is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Reliance Pharmaceuticals Private Li is ₹0.25 ( Cr.) .

About Reliance Pharmaceuticals Private Limited

No data to display
You have 0 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.